SHPH
NASDAQShuttle Pharmaceuticals Holdings Inc.
Price$0.51-0.00 (-0.23%)
02:15 PM03:15 PM
News · 26 weeks27+20%
2025-12-072026-05-31
Mix1690d
- SEC Filings11(69%)
- Offering3(19%)
- Other1(6%)
- Insider1(6%)
Latest news
25 items- INSIDERSEC Form 3 filed by new insider Trasolini Ryan3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Issuer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form D filed by Shuttle Pharmaceuticals Holdings Inc.D - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 10-Q filed by Shuttle Pharmaceuticals Holdings Inc.10-Q - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRShuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining RigsInitial Mining Fleet Targeted for Deployment Within 60 Days of Receipt; To Mine DOGE and LTC and Accumulate Mined Coins as Long-Term Treasury AssetsGaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ:SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously announced merger with United Dogecoin Inc. ("United Dogecoin"), and the confirmation of a purchase order granting the Company the option to purchase up to 3,000 next-generation ElphaPex Scrypt mining rigs ("Mining Rigs") for use in the Company's Dogecoin (DOGE) and Litecoin (LTC) merge-mining operations. As previously reported on Shuttle's Current R
- SECSEC Form DEFA14A filed by Shuttle Pharmaceuticals Holdings Inc.DEFA14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRE.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin MinerNEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced it served as exclusive M&A advisor and placement agent in connection with the successful closing of Shuttle Pharmaceuticals Holdings, Inc.'s (NASDAQ:SHPH) acquisition of United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. The transaction, completed pursuant to a definitive merger agreement, resulted in United Dogecoin merging into a wholly owned subsidiary of Shuttle Pharmaceuticals, creating one of the largest publicly traded Dogecoin mining platforms. In connection with the mer
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRShuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin MinerThe combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrateGaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ:SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on May 4, 2026. United Dogecoin's competitive adv
- SECSEC Form DEF 14A filed by Shuttle Pharmaceuticals Holdings Inc.DEF 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form PRE 14A filed by Shuttle Pharmaceuticals Holdings Inc.PRE 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 10-K filed by Shuttle Pharmaceuticals Holdings Inc.10-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRE.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public OfferingNEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced that it acted as the exclusive placement agent in connection with a $3.5 million public offering by Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharmaceuticals" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development. Shuttle Pharmaceuticals entered into a securities purchase agreement with investors for the issuance and sale of 2,238,800 shares of common stock and pre-funded warrants to purchase 4,761,200 shares of common s
- SECSEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECAmendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc.S-1/A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form S-1 filed by Shuttle Pharmaceuticals Holdings Inc.S-1 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- INSIDERSEC Form 3 filed by new insider Liang Yuying3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Issuer)
SHPH FAQ
5 questionsWhere does SHPH stock trade?
Shuttle Pharmaceuticals Holdings Inc. (SHPH) is listed on NASDAQ.What sector and industry is SHPH in?
Shuttle Pharmaceuticals Holdings Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Shuttle Pharmaceuticals Holdings Inc. go public?
Shuttle Pharmaceuticals Holdings Inc. (SHPH) completed its IPO in 2022.What companies are similar to SHPH?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare SHPH side-by-side with any of them on Quantisnow.How can I track SHPH on Quantisnow?
Quantisnow aggregates Shuttle Pharmaceuticals Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SHPH to receive live email and push alerts on every new disclosure.